India

India’s Panacea Biotec To Make 100 Million Sputnik Vaccine Doses Yearly: Report

The Russian Direct Investment Fund did not say when production would begin.

Moscow:

Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia’s Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.

RDIF did not say when production would begin.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

Source link

marathi24news.online

Leave a Reply